You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

BLINCYTO Drug Profile

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: BLINCYTO

Patents:	18
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for BLINCYTO

Recent Clinical Trials for BLINCYTO

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
University of California, San Francisco	Phase 2
French Innovative Leukemia Organisation	Phase 2
Novartis Pharmaceuticals	Phase 3

See all BLINCYTO clinical trials

Company Disclosures: US Patents for BLINCYTO

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Micromet AG (Munich, DE)	2018-04-21	RX	Orphan	company
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Micromet AG (Munich, DE)	2018-04-21	RX	Orphan	company
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Micromet AG (Munich, DE)	2025-12-16	RX	Orphan	company
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Micromet AG (Munich, DE)	2029-10-27	RX	Orphan	company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for BLINCYTO

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	AbbVie Stemcentrx LLC (North Chicago, IL)	2033-02-08	RX	Orphan	search
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Advenchen Pharmaceuticals, LLC (Moorpark, CA)	2035-05-04	RX	Orphan	search
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX	Orphan	search
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Cipla Limited (Mumbai, IN)	2036-06-30	RX	Orphan	search
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Calithera Biosciences, Inc. (South San Francisco, CA)	2035-10-05	RX	Orphan	search
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	HANGZHOU DAC BIOTECH CO., LTD. (Hangzhou, CN)	2035-07-15	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for BLINCYTO

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2011051307	Start Trial
Brazil	9909860	Start Trial
Canada	2633594	Start Trial
Spain	2532124	Start Trial
China	110292580	Start Trial
Israel	138857	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Moodys

Harvard Business School

Boehringer Ingelheim

AstraZeneca

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.